Biochip Technology - DNA Biochips

PerkinElmer Life Sciences, a world leader in the development of new genetics and biochip technology for the pharmaceutical industry, was formed from NEN Life Science Products and the International Wallac Group. PerkinElmer Life Sciences has been at the forefront in the development and production of new drug discovery genetic disease screening tools for researchers in academia and the biotechnology, clinical, and pharmaceutical industries. The company has been the world’s largest provider of technology and solutions for automated liquid handling and sample preparation equipment and genetic disease screening materials.

The company’s directive is to increase the productivity of the drug discovery process in order to reduce the time for the development of effective therapeutic drugs. One of the company’s greatest strengths is its experience and know-how in the areas of liquid handling, sample preparation, chemistry, detection, and informatics. These disciplines are critical building blocks in the development and delivery of new products and solutions to meet needs in the drug development industry.

PerkinElmer Life Sciences completed the integration of NEN Life Sciences and closed the acquisition of Packard BioScience in 2001. The company has expanded its position in the market by repositioning its business into high-growth areas, and has enhanced its position as a technology leader further by launching a record number of new products and technologies. These new products and technologies fall within a number of targeted areas with applications in DNA analysis, gene sequencing, genome mapping, proteomics, genomics, drug discovery, and genetic disease screening.

• HOME
• LINKS